Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
Saved in:
Main Authors: | Alexander Zarbock, Lakhmir Chawla, Rinaldo Bellomo |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7fbde3e1be2244cbbc64f09f1ad0a3e3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The obesity paradox and hypoglycemia in critically ill patients
by: Drago Plečko, et al.
Published: (2021) -
Association between longer duration of citrate accumulation and 90-day mortality of acute-on-chronic liver failure
by: Ming Wang, et al.
Published: (2021) -
Epidemiology of Bleeding in Critically Ill Children With an Underlying Oncologic Diagnosis
by: Juliana Romano, MD, et al.
Published: (2021) -
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
by: Douglas D. Fraser, MD, PhD, et al.
Published: (2020) -
Experience With Cardiology-Oriented Outcomes in Critically Ill Patients With Coronavirus Disease 2019
by: Randi Connor-Schuler, MD, et al.
Published: (2020)